Form 8-K - Current report:
SEC Accession No. 0001213900-25-007705
Filing Date
2025-01-29
Accepted
2025-01-29 09:27:10
Documents
17
Period of Report
2025-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0229055-8k_osthera.htm   iXBRL 8-K 54843
2 FORM OF WARRANT ea022905501ex4-1_osthera.htm EX-4.1 98101
3 ASSET PURCHASE AGREEMENT, DATED AS OF JANUARY 28, 2025, BETWEEN OS THERAPIES INC ea022905501ex10-1_osthera.htm EX-10.1 87545
4 FORM OF REGISTRATION RIGHTS AGREEMENT ea022905501ex10-2_osthera.htm EX-10.2 123847
5 PRESS RELEASE, DATED JANUARY 29, 2025 ea022905501ex99-1_osthera.htm EX-99.1 20116
  Complete submission text file 0001213900-25-007705.txt   650424

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ostx-20250128.xsd EX-101.SCH 3024
7 XBRL LABEL FILE ostx-20250128_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE ostx-20250128_pre.xml EX-101.PRE 22365
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0229055-8k_osthera_htm.xml XML 3811
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42195 | Film No.: 25567005
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)